Hints and tips:
...“I feel very strongly that we should get as many shots in arms as possible, right away,” Mr Gottlieb told USA Today last week. “The reality is that one dose is partially protective....
...The pharmaceutical and healthcare sectors have been among the most active with $479bn worth of transactions announced....
...It was once a Wall Street darling, executing an inversion deal with Actavis and other aggressive acquisitions. As its growth prospects slowed, investors grew restless....
David Tepper’s Appaloosa hedge fund had been instigating for change
...A former Bausch & Lomb executive, the 49-year-old built Allergan through a succession of deals that began in 2013 when the company he ran, then called Actavis, bought Ireland-headquartered Warner Chilcott...
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
...“Anyone with the appetite and dollars to buy can, whether it’s a Patrick Soon-Shiong [the pharmaceuticals billionaire who owns the LA Times] or an Alden.”...
...The companies now under investigation are: Heritage Pharmaceuticals, Inc.; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA;...
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...Allergan received a 10 per cent stake, or 100m shares, in Teva last year after it agreed to sell its generics business Actavis to the Israeli drugmaker last year....
...The relevant SEC filings were made by Allergan, Inc. prior to its acquisition by Actavis plc....
...Mass drug administration, supported by donations from a dozen pharmaceutical groups, plays an important part in this success. Fresh innovation is needed to produce better medicines and diagnostics....
...Taking the podium alongside Mr Gou at the White House, President Trump said it was a “great day” for “everyone who believes in Made in the USA” and claimed personal credit for Mr Gou’s investment....
...The closely watched case not only opens up the medicine to more competition in the UK, but tests the ability of pharmaceuticals companies to defend patents for “secondary uses” after they lose market exclusivity...
...Mr Schneider’s background in healthcare suggests he will seek growth opportunities for Nestlé’s fledgling “health science” division, which is pushing the group closer towards a pharmaceuticals business....
...At Allergan, however, he said he was “very supportive” of Mr Saunders, a powerful player in the pharmaceuticals industry’s recent frenzy of dealmaking....
...Mr Soon-Shiong, 63, is a surgeon and scientist, known for pioneering diabetes and cancer therapies and has founded a number of pharmaceuticals companies, including American Pharmaceutical Partners and Abraxis...
...In 2013 Ireland-based Warner Chilcott bought US-based Actavis, then in 2015, Actavis bought US-based Allergan....
...Allergan, previously known as Actavis, was itself one of numerous lesser-known US companies to have “redomiciled” to Ireland or other lower-tax countries....
...That transaction transformed the company, then known as Actavis, from a manufacturer of generic copycat medicines into a branded drugmaker. “Brent is a bold guy,” says one investor....
...Dechra Pharmaceuticals, the veterinary medicines maker, was down 3.7 per cent to £11.34 after Jefferies restarted coverage with “hold” advice....
...A California billionaire who has long coveted the Los Angeles Times has acquired a 13 per cent stake in Tribune Publishing, its parent company, which is being stalked by rival Gannett, the owner of USA Today...
...In 2013, US-based Actavis bought Ireland-headquartered Warner Chilcott, paving the way for the company to relocate its tax base away from the US and paved the way for a series of aggressive acquisitions...
International Edition